Efficacy and Safety of Dual Therapy With Dolutegravir/Lamivudine in Treatment-naive Persons With CD4 Counts amp;lt;200/mm3: 48-Week Results of the DOLCE Study

Journal:

Clinical Infectious Diseases

Published:

2025-08-28

DOI:

10.1093/cid/ciaf415

Affiliations:

14

Authors:

15

Go to article

Institutions	Authors	Share
Huesped Foundation (FH), Argentina	5.000000	0.33
Hospital Argerich, Argentina	1.000000	0.07
Hospital de Infecciosas Francisco Javier Muñiz, Argentina	1.000000	0.07
Tropical Medicine Foundation Doctor Heitor Vieira Dourado (FMT-HVD), Brazil	1.000000	0.07
Hospital General de Agudos "Dr. J. A. Fernandez", Argentina	1.000000	0.07
Centro de Referência e Treinamento DST/Aids-SP, Brazil	1.000000	0.07
Hospital de Clínicas de Porto Alegre (HCPA), UFRGS, Brazil	1.000000	0.07
Instituto de Infectologia Emílio Ribas, Brazil	1.000000	0.07
CAICI Institute, Argentina	1.000000	0.07
Hospital Geral de Nova Iguaçu (HGNI), Brazil	0.500000	0.03
Oswaldo Cruz Foundation (FIOCRUZ), Brazil	0.500000	0.03
Fundação Bahiana de Infectologia (FBaI), Brazil	0.333333	0.02
University Hospital Professor Edgard Santos (HUPES), UFBA, Brazil	0.333333	0.02
Brazilian Company of Hospital Services (EBSERH), Brazil	0.333333	0.02

Interested in Clinical Sciences?